S
ASND icon

SignatureFD’s Ascendis Pharma A/S ASND Stock Holding History

SignatureFD’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$194K Buy
727
+27
+4% +$6.31K ﹤0.01% 1112
2026
Q1 		$160K Buy
700
+10
+1% +$2.24K ﹤0.01% 1114
2025
Q4 		$147K Buy
690
+8
+1% +$1.65K ﹤0.01% 1131
2025
Q3 		$136K Buy
682
+25
+4% +$4.66K ﹤0.01% 1136
2025
Q2 		$113K Buy
657
+17
+3% +$2.77K ﹤0.01% 1186
2025
Q1 		$99.8K Sell
640
-52
-8% -$7.43K ﹤0.01% 1215
2024
Q4 		$95.3K Buy
692
+6
+0.9% +$789 ﹤0.01% 1253
2024
Q3 		$102K Buy
686
+80
+13% +$10.8K ﹤0.01% 1207
2024
Q2 		$82.6K Sell
606
-46
-7% -$6.26K ﹤0.01% 1272
2024
Q1 		$98.6K Buy
652
+89
+16% +$12.7K ﹤0.01% 1198
2023
Q4 		$70.9K Sell
563
-235
-29% -$23.4K ﹤0.01% 1300
2023
Q3 		$74.7K Buy
798
+193
+32% +$18.1K ﹤0.01% 1203
2023
Q2 		$54K Sell
605
-672
-53% -$58.5K ﹤0.01% 1382
2023
Q1 		$137K Sell
1,277
-64
-5% -$7.32K ﹤0.01% 879
2022
Q4 		$164K Buy
1,341
+49
+4% +$5.69K ﹤0.01% 780
2022
Q3 		$133K Buy
1,292
+500
+63% +$47.4K ﹤0.01% 821
2022
Q2 		$74K Buy
792
+529
+201% +$49.9K ﹤0.01% 1112
2022
Q1 		$31K Sell
263
-393
-60% -$45.5K ﹤0.01% 1609
2021
Q4 		$88K Sell
656
-2
-0.3% -$297 ﹤0.01% 1079
2021
Q3 		$105K Buy
658
+176
+37% +$24.1K ﹤0.01% 946
2021
Q2 		$63K Buy
482
+125
+35% +$16.7K ﹤0.01% 1162
2021
Q1 		$46K Buy
357
+74
+26% +$11.2K ﹤0.01% 1203
2020
Q4 		$47K Buy
283
+61
+27% +$10.1K ﹤0.01% 1108
2020
Q3 		$34K Buy
222
+147
+196% +$21.1K ﹤0.01% 1139
2020
Q2 		$11K Buy
75
+43
+134% +$5.9K ﹤0.01% 1529
2020
Q1 		$4K Buy
+32
New +$4.16K ﹤0.01% 1718

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

SignatureFD's ASND Position: Q2 2026 in Review

SignatureFD increased its Ascendis Pharma A/S (ASND) stake by 3.9% in Q2 2026, buying an estimated $6.31K and bringing the position to 727 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

SignatureFD first reported a position in ASND in Q1 2020 and has held it in 26 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • SignatureFD held 727 shares of Ascendis Pharma A/S worth $194K as of Q2 2026.
  • SignatureFD bought 27 Ascendis Pharma A/S shares in Q2 2026, an estimated $6.31K.
  • Ascendis Pharma A/S made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1112 holding.
  • SignatureFD first reported a position in Ascendis Pharma A/S in Q1 2020 and has held it in 26 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.